By Sandeep Ahuja | CEO
Dear Friend,
You will be delighted to know that eminent Professor and TB expert, Marc Lipman, has carried out extensive research to analyze OpASHA’s results and use of eCompliance to ensure full treatment. His research paper for Public Health Action states that OpASHA achieved an exceptionally high Treatment Success Rate, “despite the fact that OpASHA works with highly vulnerable patients” who are far more difficult to treat than usual. Lipman goes on to say, ‘the age and sex distribution of TB patients treated by OpASHA may reflect its aim to "reach patients who otherwise may never receive care."
Read the full paper here
Also, experts from the World Bank have prepared a case study on Operation ASHA, which states “OpASHA offers a low-cost, highly leveraged operating model which enjoys high community and partner engagement.” This also states that MDR-TB patients incur huge out-of-pocket expenses ($2500/1,00,000 Lakh Rupees) which they can hardly afford. By turning the tap off MDR-TB, Operation ASHA is saving lives, giving health, and lifting patients out of poverty
There is an urgency about our work, as you, our supporters and donors will understand very well. Of the 10.9 million people who fall sick of TB each year, 4 million go missing. An immediate need is to scale operations to identify and treat these missing patients, who are often marginalized and live in hard to reach areas.
OpASHA media mentions:
You can follow OpASHA's CEO Mr. Sandeep Ahuja(@sandeepahuja12) and President Dr. Shelly Batra (@shells1857) on Twitter.
Donation Utilization:
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.